Zimperium MTD
Zimperium Mobile Threat Defense (MTD) -formerly known as zIPS- is a privacy-first application that provides comprehensive mobile security to the enter
About this Tool
Zimperium Mobile Threat Defense (MTD) -formerly known as zIPS- is a privacy-first application that provides comprehensive mobile security to the enter
Zimperum’s on-device, machine learning-powered detection is capable of scaling with the needs of the modern workforce, securing devices against the most advanced threats. Zimperium enables enterprises to support and secure BYO an
Pros & Cons
✓ Pros
- ✓Mobile Application Protection Suite | MAPS
- ✓Mobile App Response Agent
- ✓Automated Security Testing
- ✓AI-powered features
- ✓Free plan or freemium pricing
✗ Cons
- ✗No native Android app
- ✗Some advanced features may require higher-tier plans
Key Features
Mobile Application Protection Suite | MAPS
Mobile App Response Agent
Automated Security Testing
Cryptographic Key Protection
Application Shielding
Runtime Protection
Mobile Threat Defense (MTD)
Mobile SOC Agent
Mobile Phishing Protection
Mobile App Vetting
📋 Scripts & Prompts for Zimperium MTD
Copy these AI-powered scripts to get maximum value from this tool. Sign up free to copy.
No scripts added for this tool yet.
Browse all Cybersecurity scripts in the Vault →🔌 MCP Servers for Zimperium MTD
Connect these MCP servers to give Claude, Cursor & Cline superpowers with this tool. Sign up free to copy install commands.
🤖 AI Agents for Zimperium MTD
Pre-built automation agents that work with this tool — import in one click. Sign up free to access.
Similar Cybersecurity Tools
Tags
Frequently Asked Questions
Zimperium MTD is available as free. Visit the tool's website for the latest pricing details and plan options.
Zimperium MTD offers a free plan. Check the website for feature limitations and upgrade options.
Zimperium MTD is available on iOS. Check the official website for the latest platform support.
Many tools offer free trials to let you test before subscribing. Check the Zimperium MTD website for current trial availability and duration.